Family, Friends, Hope, Strength, and Prayer
Susan Wells had chemotherapy but her treatment took a detour into more chemo and a clinical trial before she had a Whipple procedure.
The Butterfly Effect and Living Every Day to My Fullest
Because Helene Avraham-Katz has the BRCA2 mutation, certain chemotherapies work better and she is eligible for specific clinical trials.
A Clinical Trial Saved My Life
Bob Minetti and his doctors believe that a clinical trial saved his life after a pancreatic cancer diagnosis.
Catching Up with Featured Patients
Catch up with the patients featured in four of our most popular stories: Lynne Holcomb, Earl Groce, Roy Vinke, and Shannon Magee.
Time and Hope
Rose farmer Michael Francis wanted more time with his family, so he joined a clinical trial to treat his stage III pancreatic cancer.
A Second Opinion Makes the Difference
Irma Infante refused to give up after a stage IV pancreatic cancer diagnosis. She went for a second opinion and better treatment options.
The Value of Molecular Profiling and Genetic Testing
Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random and not inherited by her children.
Genetic Testing Leads Me to a PARP Inhibitor Trial
Harvey Parker had genetic testing as part of his initial pancreatic cancer treatment. The BRCA2 mutation led him to a PARP inhibitor clinical trial when the cancer returned.
Picking a Clinical Trial for Pancreatic Cancer Treatment
When Robert Weker was diagnosed with pancreatic cancer, he believed a clinical trial was his best chance of reducing the tumor enough for a Whipple.
My Pancreatic Cancer Clinical Trial Journey
After starting pancreatic cancer treatment, Davi D’Agostino discovered she has the BRCA2 mutation, which made her eligible for a clinical trial.